The Effect of Probiotics on Obesity. Metabolic Endotoxemia and Inflammation
The Effect of Probiotics on Obesity. Metabolic Endotoxemia and Inflammation
NCT ID: NCT03883685 Phase: NA Status: COMPLETED Enrollment: 80 Completion: 2019-09-01
Conditions
Metabolic Syndrome
Interventions
Probiotane, Placebo
Summary
In spite of the growing evidence for the beneficial effects of probiotics, their anti-obesity effects are not well examined. No previous studies were conducted in this research area in the UAE. Hence, the aims of this study are to 1) Investigate the link between metabolic derangements associated with obesity and levels of LPS and LBP; 2) Study the relatedness of low grade inflammation with the ME; 3) Investigate the food intake assessment; and 4) Investigate the effectiveness of probiotics supplement on the obesity, ME and inflammation.
This project will have two phases: 1) a cross-sectional, in which 250 adults will be recruited for the collection of anthropometric measures, food intake, and fasting blood samples to measure serum LPS, LBP, Lipid profile, IR, insulin-like growth factor, hs-CRP, IL-6, and glucose. 2) Intervention phase, in which 50 overweight subjects will be randomly assigned to either receive a daily probiotic (25 subjects) or a placebo capsule (25 subjects) during the intervention period.
Primary Outcome
80 participants characterized with obesity will be assessed for endotoxemia using LAL Chromogenic Endpoint Assay